Fibrinogen controls human platelet fibronectin internalization and cell-surface retention

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 8, 2007, Pages 1740-1746

  Zhai, Zhimin ^a   Wu, J ^a   Xu, X ^a   Ding, K ^a   Ni, R ^a   Hu, W ^b   Sun, Z ^a   Ni, Heyu ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Factor XIII; Fibrin; Fibrinogen; Fibronectin; Hemostasis; Hypofibrinogenemic patient; Platelet aggregation; Thrombosis

Indexed keywords

FIBRIN; FIBRIN ANTIBODY; FIBRINOGEN; FIBRONECTIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; ARTICLE; CASE REPORT; CELL SURFACE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYPOFIBRINOGENEMIA; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; INTERNALIZATION; MALE; PARENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; THROMBOCYTE AGGREGATION;

ADULT; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; CELL MEMBRANE; CONSANGUINITY; FACTOR VIII; FIBRINOGEN; FIBRONECTINS; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; THROMBOSIS;

EID: 34447640157     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02625.x     Document Type: Article

References (25)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
2. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997; 78: 611-6.
3. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-92.
4. Yang H, Reheman A, Chen P, Zhu G, Hynes RO, Freedman J, Wagner DD, Ni H. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost 2006; 4: 2230-7.
5. Ni H, Papalia JM, Degen JL, Wagner DD. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 2003; 102: 3609-14.
6. Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, Fassler R, Hynes RO, Wagner DD. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003; 100: 2415-9.
7. Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 2006; 107: 3555-63.
8. Cho J, Degen JL, Coller BS, Mosher DF. Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets. Effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J Biol Chem 2005; 280: 35490-8.
9. Ni H. Unveiling the new face of fibronectin in thrombosis and hemostasis. J Thromb Haemost 2006; 4: 940-2.
10. Xu X, Wu J, Zhai Z, Zhou R, Wang X, Wang H, Ding K, Sun Z, Ni H. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia. Thromb Haemost 2006; 95: 931-5.
11. Reheman A, Gross P, Yang H, Chen P, Allen D, Leytin V, Freedman J, Ni H. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005; 3: 875-83.
12. Plow EF, McEver RP, Coller BS, Woods VL Jr. Marguerie GA and Ginsberg MH. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets. Blood 1985; 66: 724-7.
13. Plow EF, Marguerie GA, Ginsberg MH. Fibronectin binding to thrombin-stimulated platelets: Evidence for fibrin(ogen) independent and dependent pathways. Blood 1985; 66: 26-32.
14. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: The responsive integrin. Cell 1991; 65: 359-62.
15. Born GV, Cross MJ. Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol 1964; 170: 397-414.
16. Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter S, Degen JL. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995; 9: 2020-33.
17. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-38.
18. Cho J, Mosher DF. Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood 2006; 108: 2229-36.
19. Cho J, Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 2006; 4: 1461-9.
20. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996; 12: 697-715.
21. Langenbach KJ, Sottile J. Identification of protein-disulfide isomerase activity in fibronectin. J Biol Chem 1999; 274: 7032-8.
22. Chen VM, Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 2006; 4: 2533-41.
23. Olorundare OE, Peyruchaud O, Albrecht RM, Mosher DF. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood 2001; 98: 117-24.
24. Hynes R Fibronectin. New York: Springer Verlag, 1990.
25. Sakai T, Johnson KJ, Murozono M, Sakai K, Magnuson MA, Wieloch T, Cronberg T, Isshiki A, Erickson HP, Fassler R. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med 2001; 7: 324-30.